Allostatech is a university spin-off developing digital health technologies for addressing problems in mental health. Our first product is a mobile application that aims to enable universal screening for anxiety and depression in early childhood at pediatric well visits. If administered for all children between the ages of 3 and 7 years old, and assuming a price of $15/use, we anticipate an annual revenue of up to $300,000,000.